CAS 261925-02-4: Benzenamine, 3-[(methylsulfonyl)methyl]-

3-(Methanesulfonylmethyl)aniline

3-(Methanesulfonylmethyl)aniline is a growth factor inhibitor that binds to the receptor-2, which is a protein tyrosine kinase. This binding inhibits the activation of endothelial cells and angiogenesis, as well as tumor growth. 3-(Methanesulfonylmethyl)aniline has been shown to inhibit the proliferation of human cancer cells in vitro by interfering with their ability to secrete vascular endothelial growth factor (VEGF). The drug also inhibits VEGFR-2 signaling pathways in endothelial cells, leading to a decrease in cell proliferation and angiogenesis. The mechanism of action is not yet fully understood.